Patent · US Active

Tricyclic prodrugs

US10538500B2 · kind B2 · utility

0Cited by

1References

13Claims

0Family size

Assignee

GLACTONE PHARMA DEVELOPMENT AB · SE

Inventors

Martin Johansson · Helsingborg, SE
Olov Sterner · Eidsvold, AU

Key dates

Filing date	Aug 9, 2018
Grant date	Jan 21, 2020
Priority date	—
Expiry date	Aug 9, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K5/06052
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Prodrugs of galiellactone, and derivatives thereof, are provided by reacting the parent compound, e.g. galiellactone, with a thiol. Such drugs may be administered orally to treat cancer and other proliferative diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.